Neurotoxicity of methamphetamine: Main effects and mechanisms.
Jayanthi S, Daiwile AP, Cadet JL.
Exp Neurol. 2021 Oct;344:113795. doi: 10.1016/j.expneurol.2021.113795. Epub 2021 Jun 26.
Risk of Incident Psychosis and Mania With Prescription Amphetamines.
Moran LV, Skinner JP, Shinn AK, Nielsen K, Rao V, Taylor ST, Cohen TR, Erkol C, Merchant J, Mujica CA, Perlis RH, Ongur D.
Am J Psychiatry. 2024 Oct 1;181(10):901-909. doi: 10.1176/appi.ajp.20230329. Epub 2024 Sep 12.
Occurrence of Psychosis and Bipolar Disorder in Individuals With Attention-Deficit/Hyperactivity Disorder Treated With Stimulants: A Systematic Review and Meta-Analysis.
Salazar de Pablo G, Aymerich C, Chart-Pascual JP, Solmi M, Torres-Cortes J, Abdelhafez N, Catalan A, Corbeil O, Adamo N, Shaw P, Fusar-Poli P, Cortese S.
JAMA Psychiatry. 2025 Nov 1;82(11):1103-1112. doi: 10.1001/jamapsychiatry.2025.2311.
Psychosis Risk With Prescription Amphetamine.
Tamminga CA.
Am J Psychiatry. 2024 Oct 1;181(10):856-857. doi: 10.1176/appi.ajp.20240732.
The unknown poison.
Mofenson HC, Greensher J.
Pediatrics. 1974 Sep;54(3):336-42.
Stimulants and narcolepsy.
Mahowald MW, Bornemann MA.
Sleep. 2005 Jun;28(6):663. doi: 10.1093/sleep/28.6.663.
Methamphetamine, neurotransmitters and neurodevelopment.
Čechová B, Šlamberová R.
Physiol Res. 2021 Dec 31;70(S3):S301-S315. doi: 10.33549/physiolres.934821.
Opioid-induced neurotoxicity.
Matzo M, Dawson KA.
Am J Nurs. 2013 Oct;113(10):51-6. doi: 10.1097/01.NAJ.0000435351.53534.83.
Methamphetamine Neurotoxicity: Neurotoxic Effects, Mechanism of Toxicity, Molecular Mechanisms and Treatment Strategies.
Saleh Al-Awthan Y, Al-Homidi MK, Albalawi AR, Almousi KI.
Pak J Biol Sci. 2024 Nov;27(12):613-625. doi: 10.3923/pjbs.2024.613.625.
Adderall® (amphetamine-dextroamphetamine) toxicity.
Fitzgerald KT, Bronstein AC.
Top Companion Anim Med. 2013 Feb;28(1):2-7. doi: 10.1053/j.tcam.2013.03.002.
